Andrei Shustov - 14 Jun 2024 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Reporting relationship: Senior Vice President, Medical
Issuer ticker: CLRB
Reported as of: 14 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2024, 17:03:28 UTC
Prior SEC filing: 12 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Christina Blakley, attorney-in-fact for Andrei Shustov

Key filing fact

Andrei Shustov filed Form 4 for Cellectar Biosciences, Inc. (CLRB) on 18 Jun 2024.

Key facts

This page summarizes Andrei Shustov's Form 4 filing for Cellectar Biosciences, Inc. (CLRB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2024, 17:03.

Change

Previous filing in this sequence was filed on 12 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLRB transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +260,000
Change %
Price: $0.000000
Shares after: 260,000
Date: 14 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 260,000
Exercise price: $2.65
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024.

Footnote F2

This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023.